Petrus Martinus Van Hagen

Title: Innovations of Petrus Martinus Van Hagen

Introduction

Petrus Martinus Van Hagen is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that interact with specific receptors in the body. His work has implications for various therapeutic applications.

Latest Patents

Petrus holds a patent for a compound titled "RGD (Arg-Gly-Asp) coupled to (neuro)peptides." This invention relates to compounds that exhibit a binding affinity for both the αvβ3 receptor and a (neuro)peptide receptor, specifically the somatostatin receptor. The compound consists of a first peptide part that includes the amino acid sequence Arg-Gly-Asp, and a second peptide part that is coupled to it, potentially via a linker. This innovative approach has the potential to enhance the efficacy of treatments targeting these receptors.

Career Highlights

Petrus is currently associated with Biosynthema Inc., where he continues to advance his research and development efforts. His work at the company focuses on creating novel compounds that can lead to breakthroughs in medical treatments.

Collaborations

Petrus collaborates with esteemed colleagues such as Marion DeJong and Eric Paul Krenning. Their combined expertise fosters an environment of innovation and discovery in their research endeavors.

Conclusion

Petrus Martinus Van Hagen is a distinguished inventor whose work in biochemistry and receptor-targeted compounds holds promise for future medical advancements. His contributions to the field are noteworthy and continue to inspire further research.